Iga Nephropathy
📧 Sign up to get email alerts when something new happens for Iga Nephropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Atacicept in Multiple Glomerular Diseases [Phase 2]
Phase 2 clinical trial evaluating atacicept in multiple glomerular diseases is currently recruiting, including primary membranous nephropath…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: A Multi-center Open Label Prospective Study on Early Initiation of Targeted-release Formulation of Budesonide in Patients With Primary IgA Nephropathy
A multi-center, open-label prospective study evaluating early initiation of a targeted-release formulation of budesonide in patients with Ig…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: A Phase IIa Clinical Study of RG002C0106 Injection in Subjects With Primary IgA Nephropathy [Phase 2]
Phase IIa clinical study of RG002C0106 injection for IgA nephropathy is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases [Phase 2]
Travere Therapeutics is running a phase 2 pediatric trial of sparsentan for proteinuric glomerular diseases, including Focal Segmental Glome…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Identification and Characterisation of IgA With Nephritogenic Potential in IgA Deposition Nephropathies (Rep-IgAN) [NA]
The document is a ClinicalTrials.gov entry announcing ongoing recruitment for a study to identify and characterize IgA with nephritogenic po…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: A Study of Telitacicept for IgA Nephropathy (TELIGAN) [Phase 3]
Phase 3 trial update for telitacicept in primary IgA nephropathy; the study is currently not recruiting.
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease [EARLY_Phase 1]
Update on an early-phase trial of anti-CD19/BCMA CAR-NK cells for B cell–mediated autoimmune diseases, with recruitment ongoing.
-
CLINICAL_TRIALS research · 2025-10-14Clinical Trial Update: An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases [Phase 1, Phase 2]
An open-label Phase 1/2 study evaluating povetacicept in autoantibody-associated glomerular diseases is active but not recruiting.
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Avacopan in Crescentic Immunoglobulin A Nephropathy (IgAN) [Phase 2]
Phase 2 trial of avacopan for Crescentic IgA nephropathy (IgA nephropathy) is currently recruiting. Sponsor: Mayo Clinic.
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: Atacicept in Subjects With IgA Nephropathy [Phase 3]
Phase 3 trial update for atacicept in IgA nephropathy (Berger disease) showing the study is currently active and not recruiting.
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Study of CM313 in Subject With IgA Nephropathy [Phase 2]
A Phase 2 clinical trial evaluating CM313 for IgA nephropathy by Keymed Biosciences, currently not yet recruiting.
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Nefecon and Ambrisentan in IgA Nephropathy [Phase 4]
A Phase 4 clinical trial evaluating Nefecon and Ambrisentan for IgA nephropathy and related kidney disease is currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: Atrasentan in Patients With Proteinuric Glomerular Diseases [Phase 2]
Phase 2 trial of atrasentan for proteinuric glomerular diseases is active but not recruiting, including IgA nephropathy, Focal segmental glo…
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: A Trial of HRS-5965 Capsule in Primary IgA Nephropathy [Phase 3]
Phase 3 trial of HRS-5965 Capsule for IgA nephropathy is currently recruiting. Sponsor: Chengdu Suncadia Medicine Co., Ltd.
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: Study of the Link Between Complement Activation and IgA Nephropathy Severity
A multi-center clinical trial sponsored by University Hospital, Strasbourg, France, is investigating the link between complement activation …
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: To Evaluate the Effect and Safety of Telitacicept and Standard Treatment for 6months in IgA Nephropathy [Phase 3]
A Phase 3 trial evaluating Telitacicept in combination with standard treatment for IgA nephropathy, with status currently ACTIVE_NOT_RECRUIT…
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: RESistance of IgA Nephropathy to Conventional and Newly-approved Therapies: an Observational, Real-life Study (RESIGAN)
An observational, real-world study called RESIGAN evaluating resistance of IgA nephropathy to conventional and newly approved therapies; rec…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Tonsillectomy and Immunosuppression in Caucasian Patients With High-risk IgA-nephropathy [NA]
Clinical trial update on tonsillectomy and immunosuppression for high-risk IgA nephropathy in Caucasian patients; the study is currently rec…
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy? [Phase 4]
A Phase 4 study in South Asia is evaluating whether adding any commonly available approved drugs to standard of care improves the two-year s…
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: Clinical Study on the Efficacy and Safety of Telitacicept in the Treatment of Pediatric IgA Nephropathy or IgA Vasculitis Nephritis [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of Telitacicept in pediatric patients with IgA nephropathy or IgA vasculitis nep…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Finerenone in Patients With IgA-nephropathy: Prospective Interventional Trial [NA]
A prospective interventional trial evaluating finerenone for IgA nephropathy is currently recruiting at Botkin Hospital, with no results rep…
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Autoimmune Protocol Diet Intervention on Proteinuria in IgA Nephropathy Patients [NA]
A clinical trial evaluating an autoimmune protocol diet to reduce proteinuria in IgA nephropathy. The study is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis
A clinical trial update from Assistance Publique - Hôpitaux de Paris describes a study on epithelial dysmetabolism and renal fibrosis in ANC…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Therapeutic Effect of Hydroxychloroquine on Immunoglobulin A (IgA) Nephropathy Course QUIgAN Study [Phase 2]
A Phase 2 clinical trial evaluating hydroxychloroquine for IgA nephropathy has been registered and is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: Evaluate the Efficacy and Safety of NTQ5082 Capsules in Patients With Primary IgA Nephropathy [Phase 2]
This clinical trial update describes a Phase 2 study of NTQ5082 capsules for Primary IgA Nephropathy; enrollment has not started yet.